When estrogen levels fall, these functions weaken simultaneously
Do you need something available right now
It hydrates scalp, supports follicle vitality, and reduces irritation and redness
This telogen effluvium results from the drug forcing resting follicles into active growth, causing existing hairs to shed and make way for new growth
A 1,000mg standard capsule that causes nausea and is only 10% absorbed provides less value than a 250mg liposomal dose that is 90% absorbed and feels great in your system

Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products